Search results

Evidence-based recommendations on bevacizumab (Avastin), with other drugs, for treating metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Published

15 December 2010

Evidence-based recommendations on trifluridine–tipiracil (Lonsurf) for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma in adults after 2 or more treatments.

Result type

Technology appraisal guidance

Published

14 December 2022

Evidence-based recommendations on paclitaxel as albumin-bound nanoparticles (nab-paclitaxel; Abraxane) for untreated metastatic pancreatic cancer in adults.

Result type

Technology appraisal guidance

Published

6 September 2017

In development [GID-TAG380] Expected publication date: TBC

Result type

Technology appraisal guidance

Status

In development

Evidence-based recommendations on ramucirumab (Cyramza) for treating advanced gastric cancer or gastro-oesophageal junction adenocarcinoma previously treated with chemotherapy.

Result type

Technology appraisal guidance

Published

27 January 2016

Evidence-based recommendations on pembrolizumab (Keytruda) for treating metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency in adults.

Result type

Technology appraisal guidance

Published

23 June 2021

Discontinued [GID-TA10322]

Result type

Technology appraisal guidance

Status

Discontinued

NICE has developed a medtech innovation briefing on Immunoscore for predicting risk of colon cancer relapse .

Result type

Medtech innovation briefing

Published

3 August 2021

Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the

Result type

Diagnostics guidance

Published

10 December 2014

This guidance has been updated and replaced by NICE guideline NG151. The recommendations on raltitrexed have been withdrawn because its use is established clinical practice.

Result type

Technology appraisal guidance

Published

24 August 2005

In development [GID-TA11580] Expected publication date: TBC

Result type

Technology appraisal guidance

Status

In development

This guidance has been replaced by NICE technology appraisal guidance 93 [Replaced by NICE guideline CG131].

Result type

Technology appraisal guidance

Published

27 March 2002

NICE has developed a medtech innovation briefing (MIB) on Caris Molecular Intelligence for guiding cancer treatment .

Result type

Medtech innovation briefing

Published

20 September 2017